Altered peptide epitopes derived from the anti-apoptotic protein 'survivin' may stimulate effective anti-glioma immune responses
Principal Investigator: Michael Ciesielski, PhD
Initiative: Glioblastoma Multiforme Grant
Institute: Roswell Park Cancer Institute
Location: Buffalo, NY